EH-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EH-301, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]